Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jakobs

Showing results (191-200 of 2,233) with videos related to

Pageof 224
Sort By:
Journal of Cyclic Nucleotide Research|November 1, 1976
Reduction of adenylate cyclase activity in lysates of human platelets by the alpha-adrenergic component of epinephrineK H Jakobs, W Saur, G Schultz
Physical Review Letters|November 13, 2007
Nonequilibrium functional renormalization group for interacting quantum systemsSeverin G Jakobs, Volker Meden, Herbert Schoeller
Endoscopy|August 8, 2001
Do we need the overtube for push-enteroscopy?C Benz, R Jakobs, J F Riemann
Current Opinion in Neurobiology|October 7, 2004
Concepts for nanoscale resolution in fluorescence microscopyStefan W Hell, Marcus Dyba, Stefan Jakobs
Naunyn-Schmiedeberg'S Archives of Pharmacology|December 1, 1982
Inactivation of the guanine nucleotide regulatory site mediating inhibition of the adenylate cyclase in hamster adipocytesK Aktories, G Schultz, K H Jakobs
Journal of Receptor Research|January 1, 1983
Inhibitory coupling of hormone and neurotransmitter receptors to adenylate cyclaseK H Jakobs, K Aktories, G Schultz
Naunyn-Schmiedeberg'S Archives of Pharmacology|June 1, 1980
Regulation of adenylate cyclase activity in hamster adipocytes. Inhibition by prostaglandins, alpha-adrenergic agonists and nicotinic acidK Aktories, G Schultz, K H Jakobs
FEBS Letters|July 11, 1983
Adenylate cyclase inhibition and GTPase stimulation by somatostatin in S49 lymphoma cyc- variants are prevented by islet-activating proteinK Aktories, G Schultz, K H Jakobs
Molecular Pharmacology|March 1, 1982
Stimulation of a low Km GTPase by inhibitors of adipocyte adenylate cyclaseK Aktories, G Schultz, K H Jakobs
Zeitschrift Fur Urologie Und Nephrologie|April 1, 1980
[Results of managing prostate adenomyomatosis over a period of 5 years]G Lehmann, J Jakobs, K P Heinze
Pageof 224

Showing results (191-200 of 2,233) with videos related to

Sort By:
Pageof 224
Journal of Cyclic Nucleotide Research|November 1, 1976
Reduction of adenylate cyclase activity in lysates of human platelets by the alpha-adrenergic component of epinephrineK H Jakobs, W Saur, G Schultz
Physical Review Letters|November 13, 2007
Nonequilibrium functional renormalization group for interacting quantum systemsSeverin G Jakobs, Volker Meden, Herbert Schoeller
Endoscopy|August 8, 2001
Do we need the overtube for push-enteroscopy?C Benz, R Jakobs, J F Riemann
Current Opinion in Neurobiology|October 7, 2004
Concepts for nanoscale resolution in fluorescence microscopyStefan W Hell, Marcus Dyba, Stefan Jakobs
Naunyn-Schmiedeberg'S Archives of Pharmacology|December 1, 1982
Inactivation of the guanine nucleotide regulatory site mediating inhibition of the adenylate cyclase in hamster adipocytesK Aktories, G Schultz, K H Jakobs
Journal of Receptor Research|January 1, 1983
Inhibitory coupling of hormone and neurotransmitter receptors to adenylate cyclaseK H Jakobs, K Aktories, G Schultz
Naunyn-Schmiedeberg'S Archives of Pharmacology|June 1, 1980
Regulation of adenylate cyclase activity in hamster adipocytes. Inhibition by prostaglandins, alpha-adrenergic agonists and nicotinic acidK Aktories, G Schultz, K H Jakobs
FEBS Letters|July 11, 1983
Adenylate cyclase inhibition and GTPase stimulation by somatostatin in S49 lymphoma cyc- variants are prevented by islet-activating proteinK Aktories, G Schultz, K H Jakobs
Molecular Pharmacology|March 1, 1982
Stimulation of a low Km GTPase by inhibitors of adipocyte adenylate cyclaseK Aktories, G Schultz, K H Jakobs
Zeitschrift Fur Urologie Und Nephrologie|April 1, 1980
[Results of managing prostate adenomyomatosis over a period of 5 years]G Lehmann, J Jakobs, K P Heinze
Pageof 224